TYK Medicines, Inc (HKG:2410)
Hong Kong · Delayed Price · Currency is HKD 6.31
+0.12 (1.94%)
Jun 18, 2026, 11:56 AM HKT
TYK Medicines Market Cap
TYK Medicines has a market cap or net worth of 2.38 billion as of June 17, 2026. Its market cap has decreased by -68.52% in one year.
Market Cap
2.38B
Enterprise Value
2.14B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
6.31
Market Cap Chart
Since August 20, 2024, TYK Medicines's market cap has decreased from 5.08B to 2.38B, a decrease of -53.13%. That is a compound annual growth rate of -33.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 2.38B | -52.21% |
| Dec 31, 2025 | 4.98B | -71.50% |
| Dec 31, 2024 | 17.48B | 244.16% |
| Aug 20, 2024 | 5.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Qyuns Therapeutics | 3.37B |
| Medtide | 3.27B |
| Shandong Boan Biotechnology | 3.04B |
| Jiangsu Recbio Technology | 2.97B |
| PegBio | 2.76B |
| BioDlink International Company | 2.74B |
| Viva Biotech Holdings | 2.45B |
| Beijing Luzhu Biotechnology | 2.44B |